The Institute of Applied Psychophysiology — research, evidence-based psychoeducation and practitioner education focused on anxiety and psychophysiology.
Applied Psychophysiology Research Limited · Registered in England and Wales · Company No. 16153717 · Threat Recalibration Therapy™
Published Outcomes and Evidence Context
| Intervention | Reported Outcome Evidence | Evidence Context |
|---|---|---|
| CBT | Results vary by study and measure | Long-term outcomes vary by population and follow-up |
| SSRIs | Results vary by medication and trial | Benefits and discontinuation outcomes vary |
| EMDR | Evidence depends on condition and protocol | Long-term evidence is condition-specific |
| Mindfulness | Evidence varies by protocol and population | Follow-up and practice vary across studies |
| TRT™ Therapy programme | 84.5% mean GAD-7 reduction (n=61) | Single-group pre/post outcomes evaluation; no direct comparison |
These approaches are not compared head-to-head here. The TRT™ Therapy figure is the mean GAD-7 change in a single-group outcomes evaluation; the other entries summarize variation across different studies and measures.
30+ Years of Research and Programme Outcomes
Established fear-learning science explains how experience and context shape threat responses. The Institute applies this science through research, structured psychoeducation and reported programme outcomes.
Recovery Options
About the Research Program
Fear is an adaptive response, and established learning science describes how experience and context shape threat responses and avoidance. The Institute of Applied Psychophysiology publishes research on anxiety and psychophysiology and provides evidence-based psychoeducation through its Threat Recalibration Therapy™ (TRT™) programme. Founded in 1996, it has more than 30 years of research and programme development.
Separately, Institute proposal material referencing CAPITA describes a 2015 NHS-scale business case with modelled potential savings; this was an economic projection, not an efficacy trial.
The Working Paper Series presents original scientific analyses of fear responses, applied psychophysiology and programme outcomes. The NHS Shropshire-commissioned GAD-7 outcomes evaluation is described below.
84.5% Mean GAD-7 Reduction in a 61-Person Evaluation
Among 61 participants, mean GAD-7 scores fell from 18.28 (severe) to 2.84 (minimal) — a statistically highly significant result (Z = −6.802, p < .001). No participant remained in the severe category at post-programme assessment.
The evaluation record identifies NHS Shropshire as commissioner and lists Martin Jensen as the author, with affiliations to Kingston University and the University of Copenhagen.
The Institute of Applied Psychophysiology Working Papers in Psychophysiology and Anxiety Recovery
The Working Paper Series presents original scientific analyses of fear responses, applied psychophysiology and programme outcomes, with named authors and references.
Threat Recalibration Therapy™: A Psychophysiological Framework for the Permanent Resolution of Anxiety Conditions
Charles G. Linden · The Institute of Applied Psychophysiology
Anxiety involves threat appraisal, learned associations, attention, avoidance, and bodily arousal. This paper describes Threat Recalibration Therapy™ (TRT™), the Institute's structured psychoeducation programme, and the rationale behind its teaching and practice. Participants learn about fear responses and anxiety-maintaining habits, including avoidance and safety behaviours, and practise changes to everyday routines and responses to intrusive thoughts. The paper reviews programme outcome measures and distinguishes observed symptom changes from claims about the neural mechanisms that produce them. It also sets out questions for further evaluation of the programme's approach.
The Failure of Existing Modalities in Anxiety Disorder Treatment: A Critical Evaluation and Case for Mechanism-First Intervention
Charles G. Linden · The Institute of Applied Psychophysiology
This paper reviews questions about treatment outcomes for anxiety and describes Threat Recalibration Therapy™ (TRT™), the Institute's structured psychoeducation programme. It discusses cognitive behavioural therapy (CBT), SSRI pharmacotherapy, and mindfulness-based interventions, noting that results depend on the population, outcome, and follow-up period studied. The paper presents a mechanism-first rationale for TRT™ and describes its educational content and structured practices. Naturalistic programme outcomes are discussed separately from comparative treatment evidence and from claims about neural mechanisms. The paper identifies questions for further evaluation rather than establishing that TRT™ is superior to other approaches or that any approach works through a single mechanism.
Threat Recalibration Therapy™: Clinical Outcomes Across a Large Naturalistic Population
Charles G. Linden · The Institute of Applied Psychophysiology
This paper reports naturalistic programme outcome data for Threat Recalibration Therapy™ (TRT™), spanning 30 years from 1996 to 2026 and including records from more than 650,000 individuals across 42 countries. Measures include GAD-7 scores at baseline, programme completion, 6-month follow-up, and 24-month follow-up, alongside PHQ-9 scores, self-reported functional impairment, and a subset of ADIS-5 assessments conducted in NHS-partnered evaluation settings. The dataset reports a post-completion recovery rate of 84.7% on the stated GAD-7 threshold (score ≤4), a 24-month relapse rate of 3.8%, and reductions in self-reported functional impairment. Subgroup results are reported across diagnostic presentations, age groups, and levels of initial symptom severity. These figures describe observed programme outcomes; naturalistic data do not establish causation or validate a particular neurobiological mechanism. The paper discusses the findings alongside published outcome data for CBT and pharmacotherapy.
Monotropic Identity Displacement: A Psychophysiological Framework for Understanding Identity Adoption in Autistic Individuals with Anxiety Conditions
Charles G. Linden · The Institute of Applied Psychophysiology
This paper proposes and details the phenomenon of Monotropic Identity Displacement (MID) — a neurobiological process specific to autistic individuals with anxiety conditions, in which the amygdala's hyperactivated threat-prediction system interacts with the monotropic attentional architecture of autism to produce deep, affect-laden absorption in identity frameworks that provide temporary relief from undifferentiated anxiety. MID is presented as a psychophysiological explanation for the significantly elevated rates of gender dysphoria, sexual identity flux, extreme political identification, and other intensive identity adoptions observed in autistic adolescents and young adults with anxiety disorders. The paper distinguishes MID from genuine identity development, argues that existing clinical frameworks misidentify anxiety-driven identity displacement as primary identity expression, and presents Threat Recalibration Therapy™ (TRT™) as the appropriate intervention — addressing the anxiety mechanism that drives the displacement rather than affirming or challenging the displaced identity per se.
The Comorbidity Fallacy: How the DSM, Psychiatric Practice, and Pharmaceutical Incentives Have Systematically Misclassified, Overmedicated, and Harmed Millions of Anxiety Sufferers
Charles G. Linden · The Charles Linden Institute
This working paper questions how co-occurring diagnoses and symptoms are interpreted in anxiety care and advances a hypothesis that some apparent comorbidity may reflect overlapping experiences or shared stress-related processes. It discusses diagnostic systems, prescribing, and the Institute's naturalistic programme outcomes. The paper's proposed single-process account, including its emphasis on HPA-axis activity, is a hypothesis rather than an established explanation for co-occurring conditions. GAD-7 and PHQ-9 scores describe self-reported symptoms and do not by themselves establish diagnoses, causation, or that one condition resolves another. The paper identifies questions for further evaluation and does not provide clinical advice.
The Psychological Cost of Lockdown and Masking Policies on Children
Charles G. Linden · The Institute of Applied Psychophysiology
This paper examines the psychological cost imposed on children and adolescents by the non-pharmaceutical interventions used during the COVID-19 pandemic, principally lockdowns, school closures and mask mandates. It argues that the risk communication surrounding SARS-CoV-2 systematically overstated the danger the virus posed to children, that this misinformation acted as an acute trigger for anxiety in children already biologically predisposed to it rather than a slow-burning stressor accumulating over years, and that the collateral damage of isolation, lost family contact, disrupted bereavement and reduced physical activity did measurable harm that is now documented in the peer-reviewed literature. It also reviews the Cochrane evidence on community masking and the surge in eating disorders, health anxiety and related conditions recorded during and after the pandemic period.
Talking Children Into Anxiety: How School Mental Health Initiatives Activate the Conditions They Aim to Prevent
Charles G. Linden · The Institute of Applied Psychophysiology
Universal mental health awareness programs, mindfulness lessons and structured emotional literacy curricula have been introduced into schools at scale over the past decade on the assumption that talking about anxiety, teaching children to label and monitor their internal states, and building general mental health awareness will reduce the prevalence of anxiety disorders in the school population. This paper reviews the evidence and finds the opposite has occurred. Reported rates of anxiety and other internalising conditions among children and adolescents have risen sharply over the same period these programs expanded. The largest and most rigorous trial of school-based mindfulness training ever conducted found no benefit on any primary outcome. Multiple controlled studies have found that some school-based mental health interventions actively increase internalising symptoms in a meaningful subgroup of participants, an effect researchers now describe openly as iatrogenic harm. This paper sets out the evidence for what Oxford researcher Lucy Foulkes has termed the prevalence inflation hypothesis, reviews the mechanism by which sustained attentional focus on internal threat cues can activate rather than deactivate a biologically predisposed anxiety response, and argues that the well-intentioned expansion of mental health talk in schools has, for a meaningful subset of children, functioned as a trigger rather than a shield.
The Biology Behind the Fiction: Threat Sensitivity, Heritability, and the Science That Inspired THE STUDY
Charles G. Linden · The Institute of Applied Psychophysiology
This working paper accompanies the publication of THE STUDY, a work of fiction by the Institute's founder. Its purpose is narrow and specific: to separate clearly what is real, published science from what is invented for the purposes of the novel's plot, and to give readers, clinicians, and researchers a straightforward account of the genuine research underpinning the book's central premise. Nothing in this paper should be read as validating the novel's fictional institution, its two-thousand-year timeline, or its central conspiracy. Those elements are invented. What follows concerns only the real science the fiction draws upon.
Institute Position Statements
Applied Psychophysiology — The Third Category of Healthcare
Published by: The Institute of Applied Psychophysiology
The Institute's position statement describes applied psychophysiology alongside physical and psychological approaches. It sets out the Institute's perspective on the field and presents its programme outcomes evaluation.
Further reading: Adoption and implementation of TRT™.
Research Advisory Board
The Institute of Applied Psychophysiology Research Advisory Board provides independent oversight of the Institute's research program. Board members review working papers prior to publication and contribute to the Institute's ongoing research agenda.
Rachel Wood MSc, RGN
Rachel Wood holds a Master of Science degree and is a Registered General Nurse with clinical experience across healthcare settings. She contributes nursing and clinical practice expertise to the Institute's research oversight.
Ben Tams
Ben Tams contributes to the Institute's research program in an advisory capacity, bringing professional expertise to the evaluation and dissemination of the Institute's clinical outcomes work.
Dr Priya Sukhtankar
Dr Priya Sukhtankar contributes medical expertise to the Institute's research advisory function, providing independent clinical perspective on the Institute's published research and outcomes evidence.
Academic Correspondence
Researchers and clinicians wishing to correspond about the Institute's published work, propose collaborative research, or request access to clinical outcomes data are invited to contact the Institute directly.
research@instituteofappliedpsychophysiology.com
